Delivery Order SPE2DB25D3020-SPE2DB25FWHPQ

Award Date 5/19/25
Potential Completion Date 5/20/25
Potential Value $16K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Dupixent 300 mg/2 ml syringes. The contract is a firm fixed-price delivery order with a ceiling value of $16,521.51 and a period of performance through April 24, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth $999,999,999.00, which serves as a comprehensive...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Dupixent 300 mg/2 ml syringes. The contract has a ceiling value of $32,461.16 and a period of performance through April 28, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Dupixent 300 mg/2 ml syringes, a medication used to treat certain medical conditions. The order has a ceiling value of $5,743.39 and is a firm fixed-price contract. The order is not a set-aside contract, indicating open competition. The contract has an ultimate completion date of April...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Dupixent 300 mg/2 ml syringes, a prescription medication, with a ceiling value of $10,350.00 and a period of performance through April 2025. The contract is not set aside and is a firm fixed-price delivery order. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Dupixent 300 mg/2 ml syringes. The contract is a firm-fixed-price delivery order with a ceiling value of $16,414.50 and a completion date of September 10, 2024. AmerisourceBergen, through its Corporate Office division, has been awarded this contract to provide the medication to support military treatment facilities and other federal...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Dupixent, a 300 mg/2 ml syringe medication, with a ceiling value of $11,090.88 and a performance period through April 2025. The contract is not set aside and is a firm fixed-price delivery order. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $36,298.23, is for the supply of Dupixent 300 mg/2 ml syringes, a prescription medication. The contract is a firm fixed-price delivery order, with an ultimate completion date of April 18, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Dupixent 300 mg/2 ml syringes, a specialty medication used for various medical treatments. The contract has a ceiling value of $10,778.02 and a period of performance through January 17, 2025. The contract is a firm fixed-price delivery order and does not have a set-aside designation,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $6,171.98 and an ultimate completion date of July 8, 2024. It is for the supply of Dupixent 300 mg/2 ml syringes, a specialty medication used for various medical conditions. The contract is a firm fixed-price delivery order and is not designated as a set-aside. AmerisourceBergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Dupixent 200 mg/1.14 ml syringes, a specialized medication. The contract has a ceiling value of $16,264.14 and runs through November 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical,...
  • SPE2DB25D3020
    Indefinite Delivery Contract
  • SPE2DB25D3020-SPE2DB25FWHPQ
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for 300 mg/2 mL syringes of the prescription medication Dupixent, with a ceiling value of $16,203.93 and a performance period ending on May 20, 2025. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers such as the Defense Health Agency and U.S. Coast Guard.

Generated 8/18/25, 9:58 AM